- Home
- CUE vs LOOP Comparison
CUE vs LOOP Comparison
Compare CUE & LOOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CUE | LOOP |
|---|---|---|
| Founded | 2014 | 2010 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.6M | 58.1M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | CUE | LOOP |
|---|---|---|
| Price | $0.26 | $0.99 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 545.8K | 82.4K |
| Earning Date | 11-12-2025 | 01-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $7,100,000.00 | ★ $11,112,000.00 |
| Revenue This Year | $36.58 | N/A |
| Revenue Next Year | $32.10 | $1,035.09 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 10901.98 |
| 52 Week Low | $0.24 | $0.85 |
| 52 Week High | $1.75 | $2.29 |
Technical Indicators
Market Signals| Indicator | CUE | LOOP |
|---|---|---|
| Relative Strength Index (RSI) | 14.00 | 39.28 |
| Support Level | $0.47 | $0.88 |
| Resistance Level | $0.51 | $1.07 |
| Average True Range (ATR) | 0.05 | 0.07 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 3.67 | 39.13 |
Price Performance
Historical ComparisonAbout CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
About LOOP Loop Industries Inc.
Loop Industries Inc. is a technology and licensing company whose mission is to accelerate the world's shift toward sustainable plastic and away from dependence on fossil fuels. The company owns patented and proprietary technology that depolymerizes no and low value waste PET plastic and polyester fiber, including plastic bottles and packaging, carpet and polyester textile of any color, transparency or condition, and even ocean plastics that have been degraded by the sun and salt, to its base building blocks.